ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors

<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

Yuchen Jiao, Chanjuan Shi, Barish H. Edil et al. · Science · 2011 · 1.7K citations

Medicine, Genetics, Oncology +17

Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions

Aaron D. Goldberg, Laura A. Banaszynski, Kyung‐Min Noh et al. · Cell · 2010 · 1.3K citations · Full text

Life Sciences, Genetics, Molecular Biology +11

Whole-genome landscape of pancreatic neuroendocrine tumours

Aldo Scarpa, David K. Chang, Kátia Nones et al. · Nature · 2017 · 1K citations

Medicine, Genetics, Oncology +14

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

Þorvarður R. Hálfdánarson, Kari G. Rabe, Joseph Rubin et al. · Annals of Oncology · 2008 · 886 citations · Full text

Medicine, Endocrinology, Oncology +15

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres

Peter W. Lewis, Simon J. Elsaesser, Kyung‐Min Noh et al. · Proceedings of the National Academy of Sciences · 2010 · 814 citations

Life Sciences, Genetics, Molecular Biology +17